Biomeme IPO

biomeme.com

Biomeme is the developer of a platform that transforms your smartphone into a mobile lab for advanced DNA diagnostics and real-time disease surveillance.

Founded2012
Total Funding to Date$5.46MM
Register for Details

For more details on financing and valuation for Biomeme, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Click here to log in

Biomeme Ticker Symbol

Biomeme does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Biomeme Stock Price

The stock price for Biomeme will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Biomeme Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
4/11/2022 Series Seed $192.57MM $XXX.XX $XXX.XX
Based on primary financings

Other companies like Biomeme in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$885.01MM
Sector